Durvalumab is an anti-cancer medication used to treat unresectable non-small cell lung cancer (NSCLC). It works by inhibiting PD-L1, enhancing the immune response against cancer cells. Durvalumab's clinical significance lies in its ability to improve survival rates in advanced cancers. In summary, Durvalumab is a crucial therapy for managing lung cancer.
Durvalumab blocks PD-L1 interactions with PD-1, enhancing T-cell activation and promoting anti-tumor immunity.
No published brands for this salt yet.